| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 487 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 452 | 2024 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 220 | 2022 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 197 | 2024 |
| Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study JP Arab, LA Díaz, N Baeza, F Idalsoaga, E Fuentes-López, J Arnold, ... Journal of hepatology 75 (5), 1026-1033, 2021 | 105 | 2021 |
| The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease LA Díaz, JP Arab, A Louvet, R Bataller, M Arrese Nature Reviews Gastroenterology & Hepatology 20 (12), 764-783, 2023 | 88 | 2023 |
| High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data LA Díaz, F Idalsoaga, M Cannistra, R Candia, D Cabrera, F Barrera, ... World journal of gastroenterology 26 (48), 7693, 2020 | 80 | 2020 |
| Alcohol consumption: medical implications, the liver and beyond V Meza, J Arnold, LA Díaz, M Ayala Valverde, F Idalsoaga, G Ayares, ... Alcohol and Alcoholism 57 (3), 283-291, 2022 | 67 | 2022 |
| Impact of public health policies on alcohol‐associated liver disease in Latin America: an ecological multinational study LA Díaz, F Idalsoaga, E Fuentes‐López, A Márquez‐Lomas, CA Ramirez, ... Hepatology 74 (5), 2478-2490, 2021 | 51 | 2021 |
| The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas LA Díaz, E Fuentes-López, G Ayares, F Idalsoaga, J Arnold, ... The Lancet Gastroenterology & Hepatology 7 (6), 552-559, 2022 | 49 | 2022 |
| Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes LA Díaz, E Fuentes-López, F Idalsoaga, G Ayares, O Corsi, J Arnold, ... Journal of hepatology 80 (3), 409-418, 2024 | 40 | 2024 |
| Current medical treatment for alcohol-associated liver disease G Ayares, F Idalsoaga, LA Díaz, J Arnold, JP Arab Journal of Clinical and Experimental Hepatology 12 (5), 1333-1348, 2022 | 37 | 2022 |
| Liver diseases in Latin America: current status, unmet needs, and opportunities for improvement LA Díaz, G Ayares, J Arnold, F Idalsoaga, O Corsi, M Arrese, JP Arab Current Treatment Options in Gastroenterology 20 (3), 261-278, 2022 | 36 | 2022 |
| NAFLD: Challenges and opportunities to address the public health problem in Latin America JP Arab, LA Díaz, M Dirchwolf, HE Mark, JV Lazarus, E Vaughan, ... Annals of hepatology 24, 100359, 2021 | 35 | 2021 |
| COVID-19 and indirect liver injury: a narrative synthesis of the evidence F Idalsoaga, G Ayares, JP Arab, LA Díaz Journal of Clinical and Translational Hepatology 9 (5), 760, 2021 | 34 | 2021 |
| Symptom profiles and risk factors for hospitalization in patients with SARS-CoV-2 and COVID-19: a large cohort from South America LA Díaz, T García-Salum, E Fuentes-López, M Ferrés, RA Medina, ... Gastroenterology 159 (3), 1148-1150, 2020 | 30 | 2020 |
| Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the … P Danpanichkul, K Suparan, P Dutta, C Kaeosri, B Sukphutanan, Y Pang, ... Metabolism 158, 155958, 2024 | 27 | 2024 |
| Public health measures and prevention of alcohol-associated liver disease G Ayares, F Idalsoaga, J Arnold, E Fuentes-López, JP Arab, LA Díaz Journal of Clinical and Experimental Hepatology 12 (6), 1480-1491, 2022 | 27 | 2022 |
| Frailty and reduced gait speed are independently related to mortality of cirrhotic patients in long-term follow-up R Soto, LA Díaz, V Rivas, E Fuentes-López, M Zalaquett, MJ Bruera, ... Annals of Hepatology 25, 100327, 2021 | 27 | 2021 |
| Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high‐risk gastro‐oesophageal varices in a Chilean cohort MI Gaete, LA Díaz, A Arenas, K González, M Cattaneo, F Fuster, ... Liver International 40 (6), 1427-1434, 2020 | 24 | 2020 |